Tumor News and Research

RSS
Study findings can guide personalized breast cancer therapies based on melatonin

Study findings can guide personalized breast cancer therapies based on melatonin

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

Oligourea-based "fake" peptides enhance options for rational drug design, shows study

Oligourea-based "fake" peptides enhance options for rational drug design, shows study

Higher degrees of necrosis are inked to poor survival in brain cancer patients

Higher degrees of necrosis are inked to poor survival in brain cancer patients

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

RNA mutations within common bacterium linked to invasive meningococcal disease

RNA mutations within common bacterium linked to invasive meningococcal disease

Testing for tumor DNA can help predict risk of relapse after transplant in DLBCL patients

Testing for tumor DNA can help predict risk of relapse after transplant in DLBCL patients

Henry Ford Health System announces receipt of $16 million gift to Henry Ford Pancreatic Cancer Center

Henry Ford Health System announces receipt of $16 million gift to Henry Ford Pancreatic Cancer Center

RUDN team suggests new tool to control inflammation in asthma patients with accompanying diseases

RUDN team suggests new tool to control inflammation in asthma patients with accompanying diseases

Study assesses different pipelines for timing mutations in cancer genomes

Study assesses different pipelines for timing mutations in cancer genomes

Novel modular design approach to antibody nanocage generation

Novel modular design approach to antibody nanocage generation

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

Researchers identify potential drug combination to treat uveal melanoma

Researchers identify potential drug combination to treat uveal melanoma

Study identifies multiple important genomic differences in BCL malignancies using genomic ancestry

Study identifies multiple important genomic differences in BCL malignancies using genomic ancestry

Researchers develop wound-healing gel based on a substance produced by Trichoderma fungi

Researchers develop wound-healing gel based on a substance produced by Trichoderma fungi

β-AR agonist therapy may prevent metastasis in oral squamous cell carcinoma

β-AR agonist therapy may prevent metastasis in oral squamous cell carcinoma

New tool to predict breast cancer recurrences

New tool to predict breast cancer recurrences

Surprising discovery reveals new target for aggressive lung adenocarcinoma

Surprising discovery reveals new target for aggressive lung adenocarcinoma

Study: Tumors with high TMB tend to respond better to immune checkpoint inhibitors

Study: Tumors with high TMB tend to respond better to immune checkpoint inhibitors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.